Colgate-Palmolive Posts In Line Q2 Earnings, Misses Revenue - Analyst Blog


Shutterstock photo

Colgate-Palmolive Co. ( CL ), a global dealer in consumer goods, reported second-quarter 2014 adjusted earnings of 73 cents per share which came in line with the Zacks Consensus Estimate. Earnings grew 4% year over year.

Colgate-Palmolive Company - Earnings Surprise | FindTheBest

Including one-time items, earnings came in at 67 cents per share, up 12% year over year.

Global sales of $4,352 million were almost flat as compared with the prior-year figure of $4,346 million. Sales benefited from 2.5% growth in volume and 1.5% rise in prices which were run down by a 4% negative impact from currency fluctuations. However, quarterly revenues missed the Zacks Consensus Estimate of $4,401 million.

On an organic basis (excluding foreign exchange, acquisitions and divestitures), the company recorded sales growth of 4%.

Adjusted gross profit margin was 58.8%, up 20 bps as the benefit from cost saving initiatives under funding-the-growth and 2012 Restructuring Program as well as higher pricing more than offset increase in raw material and packaging costs.

Adjusted selling, general and administrative (SG&A) expenses, as a percentage of revenues, fell 40 basis points (bps) to 34.4% from the year-ago quarter. The decline was mainly due to lower advertising investment partly offset by higher overhead expenses both as a percentage of sales.

In the quarter, adjusted operating profit of $1,056 million increased 2% from the year-ago period while operating margin improved 60 bps to 24.3%.

On a year-to-date basis, Colgate-Palmolive's market share of global toothpaste and manual toothbrushes reached 44.4% and 33.5%, respectively. Additionally, the company's mouthwash business made significant progress, with its global market share reaching a record 17.2% in the year-to-date period, an 80 bps improvement from the prior-year quarter.

Segment Discussion

North America sales (18% of total sales) rose 1% in the quarter, driven by a 2.5% rise in unit volume, partly offset by the negative impact of 1% from lower pricing and 0.5% from foreign exchange. On an organic basis, sales increased 1.5%.

The segment's operating profit grew 2% to $231 million while operating margin expanded 20 bps to 30%. The year-over-year rise in operating margin was chiefly due to lower SG&A expenses as a percentage of net sales, partly offset by a lower gross margin.

Latin America sales (27% of total sales) declined 4% year over year, as the benefit of a 5% increase in pricing and 3% unit volume growth was more than offset by a negative foreign exchange impact of 12.0%. Volume gains were most prominent in Venezuela, Mexico and Colombia. On an organic basis, sales increased 8%.

Operating profit decreased 12% to $311 million while as a percentage of sales, it contracted 220 bps to 25.3% primarily due to a lower gross profit margin and higher SG&A expenses as a percentage of sales.

Europe/South Pacific sales (20% of total sales) grew 6% year over year, primarily benefiting from a 4.5% rise in unit volume and a 4% positive impact from foreign exchange. However, these were partially offset by a 2.5% impact from lower pricing. Volume gains were primarily led by Australia and France. Organic sales for the region were up 2.5%.

Operating profit increased 20% year over year to $227 million. Furthermore, the operating margin for the region expanded 310 bps to 26% primarily attributable to higher gross profit margin and lower SG&A expenses as a percentage of sales.

Asia sales (15% of total sales) fell 1.5% owing to 4.5% negative impact from foreign currency, which more than offset a 2.5% increase in unit volume and a 0.5% rise in pricing. Volume growth was primarily led by gains in India, Thailand and the Philippines. On an organic basis, sales grew 3%.

Operating profit rose 3% to $178 million. Operating margin expanded 120 bps to 29.2%, on account of lower SG&A expenses as a percentage of sales.

Africa/Eurasia sales (7% of total sales) also dropped 1% year over year due to a 7.5% negative impact from foreign currency exchange, which more than offset the benefit of 5.5% growth in unit volume and 1% increase in prices. Volume gains were primarily led by Russia, South Africa and Turkey. Organic sales for the region rose 6.5%.

Operating profit decreased 11% year over year to $58 million in the quarter while as a percentage of sales, it contracted 210 bps to 18.8%. The decrease was mainly due to lower gross profit margin and increased SG&A expenses as a percentage of sales.

Hill's Pet Nutrition sales (13% of total sales) grew 2%. Pricing had a 4% positive impact on sales growth while foreign exchange negatively impacted sales by 0.5%. Unit volume decreased 1.5% due to volume declines in the U.S., and Japan, partly offset by volume gains in Russia. On an organic basis, sales rose 2.5% from the year-ago quarter.

Operating profit improved 7% to $146 million, while operating profit margin expanded 130 bps to 26.1%. The rise in operating profit was due to higher gross margin.

Other Financial Details

Colgate-Palmolive, which competes with The Procter & Gamble Co. ( PG ) and Unilever plc ( UL ), ended the quarter with cash and cash equivalents of $1,161 million, total debt of $6,061 million and shareholders' equity of $1,779 million.

Net cash provided by operating activities came in at $1,389 million for the first half.

Other Stocks to Consider

Currently, Colgate-Palmolive carries a Zacks Rank #2 (Buy). Another stock that warrants a look in the retail space is Citi Trends, Inc. ( CTRN ), which sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PROCTER & GAMBL (PG): Free Stock Analysis Report

UNILEVER PLC (UL): Free Stock Analysis Report

COLGATE PALMOLI (CL): Free Stock Analysis Report

CITI TRENDS INC (CTRN): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Earnings , Stocks
More Headlines for: PG , UL , CL , CTRN

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by